Ace the CRNI Challenge 2025 – Infuse Your Career with Success!

Question: 1 / 400

Which antineoplastic agent has a recommended total cumulative dose limit of 1400 mg/m²?

Carmustine

Carmustine is the antineoplastic agent that is associated with a recommended total cumulative dose limit of 1400 mg/m². This dose limit is significant because exceeding it can result in severe toxicities, particularly myelosuppression leading to a high risk of infections and bleeding complications. Carmustine is an alkylating agent that is often used in the treatment of certain types of cancers, including brain tumors and lymphomas, and its unique formulation allows for prolonged exposure in tissues. Understanding cumulative dose limits is crucial for patient safety and for preventing long-term complications from chemotherapy. Being aware of such dosing guidelines, especially for drugs like Carmustine, helps healthcare professionals manage therapy effectively and mitigate potential side effects.

Get further explanation with Examzify DeepDiveBeta

Gemcitabine

Paclitaxel

Docetaxel

Next Question

Report this question

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy